What is Zacks Research’s Estimate for PAHC Q2 Earnings?

Phibro Animal Health Co. (NASDAQ:PAHCFree Report) – Investment analysts at Zacks Research upped their Q2 2026 EPS estimates for shares of Phibro Animal Health in a note issued to investors on Tuesday, January 7th. Zacks Research analyst R. Department now expects that the company will post earnings of $0.49 per share for the quarter, up from their previous estimate of $0.47. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.62 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q3 2026 earnings at $0.36 EPS, Q4 2026 earnings at $0.50 EPS, FY2026 earnings at $1.66 EPS and FY2027 earnings at $2.12 EPS.

Other equities research analysts also recently issued reports about the company. Morgan Stanley increased their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Barclays increased their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 12th. Finally, StockNews.com upgraded shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 4th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $20.50.

Get Our Latest Stock Analysis on Phibro Animal Health

Phibro Animal Health Price Performance

PAHC opened at $21.48 on Thursday. Phibro Animal Health has a 12-month low of $10.03 and a 12-month high of $25.98. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The firm has a market capitalization of $870.00 million, a P/E ratio of 49.95, a PEG ratio of 0.58 and a beta of 0.53. The stock has a fifty day moving average of $22.81 and a 200-day moving average of $21.06.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were issued a dividend of $0.12 per share. The ex-dividend date was Wednesday, November 27th. This represents a $0.48 annualized dividend and a dividend yield of 2.23%. Phibro Animal Health’s dividend payout ratio is 111.63%.

Hedge Funds Weigh In On Phibro Animal Health

Hedge funds have recently added to or reduced their stakes in the company. American Century Companies Inc. lifted its holdings in Phibro Animal Health by 119.6% in the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock worth $5,822,000 after purchasing an additional 189,068 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Phibro Animal Health by 5.7% in the second quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock worth $13,005,000 after buying an additional 42,086 shares during the last quarter. Sofinnova Investments Inc. bought a new stake in shares of Phibro Animal Health during the 2nd quarter worth $3,975,000. Hsbc Holdings PLC acquired a new position in Phibro Animal Health in the 2nd quarter valued at $238,000. Finally, Public Sector Pension Investment Board raised its holdings in Phibro Animal Health by 6.1% in the 2nd quarter. Public Sector Pension Investment Board now owns 44,796 shares of the company’s stock worth $751,000 after acquiring an additional 2,583 shares during the period. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Read More

Earnings History and Estimates for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.